Myriad Genetics Grows Women's Health Biz With Counsyl Acquisition
Executive Summary
Myriad Genetics has signed an agreement to acquire reproductive- testing company Counsyl for $375m. The acquisition is Myriad's largest acquisition to date and entry into the reproductive testing market.
You may also be interested in...
Device/Diagnostics Quarterly Dealmaking Statistics, Q2 2018
Second quarter device financing totaled $3.4 billion, less than half of the Q1 aggregate. Conversely, the $10.6 billion in device M&As was a 58% upsurge over the previous quarter. Like the device trends, total Q2 diagnostics financings (at $959 million) showed a 36% decline from Q1, while the $4.8 billion in M&A volume exhibited a significant increase over the previous quarter.
M&A Analysis – Acquisitions Come What May
The steady flow of medtech M&A deal-making continued in May; Medtech Insight recorded 16 acquisitions last month, including a global merger of Sivantos and Widex to form the world's third-largest hearing-aid company, ready to challenge market leaders Sonova and William Demant.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.